Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

NCT00445705 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

211

Enrollment

INDUSTRY

Sponsor class

Stopped This study was terminated early due to company decision. Part B was never conducted.

Conditions

Fibromyalgia

Interventions

DRUG: placebo
DRUG: AGN 203818
DRUG: AGN 203818
DRUG: AGN 203818

Sponsor

Allergan